Shares of OKYO Pharma Limited (LON:OKYO – Get Free Report) fell 24.3% on Thursday . The stock traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.40 ($0.02). 364,142 shares were traded during mid-day trading, a decline of 16% from the average session volume of 431,999 shares. The stock had previously closed at GBX 1.85 ($0.02).
OKYO Pharma Stock Down 24.3 %
The stock has a 50-day moving average price of GBX 1.40 and a 200-day moving average price of GBX 1.40. The company has a debt-to-equity ratio of 1.65, a current ratio of 0.83 and a quick ratio of 2.65. The company has a market capitalization of £23.24 million, a P/E ratio of -140.00 and a beta of -0.06.
About OKYO Pharma
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain.
Further Reading
- Five stocks we like better than OKYO Pharma
- 3 REITs to Buy and Hold for the Long Term
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 3 Penny Stocks Ready to Break Out in 2025
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for OKYO Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OKYO Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
